Yun Li

Yun Li

Auto-generated profile, based on publicly available information

Yun Li

National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University , Guangzhou 510120

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2022 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
YLYun Li
Yun Li
JLJunfeng Lin
Junfeng Lin
ZWZihui Wang
Zihui Wang
ZWZhufeng Wang
Zhufeng Wang
LTLunfang Tan
Lunfang Tan
JZJinping Zheng
Jinping Zheng
Background: In the 2021 ERS/ATS interpretive strategies for routine lung function tests, a positive bronchodilator response (BDR) was updated as a change of > 10% relative to the predicted value in forced expiratory volume in 1 second (FEV1) or forced vital capacity (FVC). We aimed to explore the differences between the 2005 and 2021 ERS/ATS criteria applied to patients with asthma as well as chronic obstructive pulmonary disease (COPD). Methods: BDR test data about asthma patients aged 6– 80 years and COPD patients aged 18– 80 years were derived from the National Respiratory Medicine Center, First Affiliated Hospital of Guangzhou Medical University, from January 2017 to March 2022. BDR results defined by the 2005 and 2021 ERS/ATS criteria were named 2005-BDR and 2021-BDR, respectively. We compared differences between 2005-BDR and 2021-BDR and analyzed the trend in the proportion of positive BDR (BDR+) with the level of airflow obstruction. Results: A total of 4457 patients with asthma and 7764 patients with COPD were included in the analysis. The percentages of 2005-BDR+ and 2021-BDR+ were 63.32% and 52.84% for asthma, 30.92% and 22.94% for COPD, respectively. Of patients with 2005-BDR+, 81.86% for asthma and 70.18% for COPD showed 2021-BDR+ results, and these patients had higher FEV1%pred, FVC%pred (all P< 0.05). Whichever BDR criterion was adopted, the proportion of BDR+ had an upward linear trend with the increased degree of airflow obstruction in COPD, but exhibited an approximate inverted U-shaped curve in asthma. In COPD, the proportion of BDRFEV1 was negatively associated with the degree of airflow obstruction, while BDRFVC was positively associated (all P< 0.05). Conclusion: Compared with 2005-BDR+, the proportion of 2021-BDR+ reduced markedly in patients with asthma and COPD, but their trends with the degree of airflow obstruction did not change. Patients with consistent BDR+ had higher initial FEV1%pred and FVC%pred.

3 January 2024 in Mycoses
Verified
Journal Article
Closed access
YLYun Li
Yun Li
DCDeyan Chen
Deyan Chen
SLShuyi Liu
Shuyi Liu
JLJunfeng Lin
Junfeng Lin
WWWei Wang
Wei Wang
JZJinping Zheng
Jinping Zheng

27 December 2024 in Medical Mycology
Verified
Journal Article
Closed access
YLYun Li
Yun Li
DCDeyan Chen
Deyan Chen
YZYouwen Zhang
Youwen Zhang
SLShuyi Liu
Shuyi Liu
LLLina Liang
Lina Liang
JZJinping Zheng
Jinping Zheng
In clinical practice, differentiating among pulmonary mucormycosis (PM), invasive pulmonary aspergillosis (IPA), and pulmonary tuberculosis (PTB) can be challenging. We aimed to evaluate the performance of chest CT-based artificial intelligence (AI) models in distinguishing among these three diseases. Patients with confirmed PM, IPA, or PTB were retrospectively recruited from three tertiary hospitals. Two models were developed: the unannotated supervised training (UST) model, trained with original CT images and the annotated supervised training (AST) model, trained with manually annotated lesion images. A network questionnaire with 20 cases was designed to assess the performance of clinicians. Sensitivity, specificity, and accuracy were calculated for both models and clinicians. A total of 61 PM cases, 136 IPA cases, and 155 PTB cases were included in the study. In the internal validation set, both models had an accuracy of 66.1%. The UST model had sensitivities of 27.3%, 73.9%, and 76.0% for PM, IPA, and PTB, while the AST model had sensitivities of 9.1%, 69.6%, and 88.0% for the same conditions. In the external validation set, both models had an accuracy of 57.6%. The UST model had sensitivities of 0, 85.7%, and 53.3% for PM, IPA, and PTB, respectively, while AST model had sensitivities of 0, 42.9% and 83.3%. A total of 112 clinicians had an accuracy of 42.9%, with sensitivities of 31.5%, 43.4%, and 48.0% for PM, IPA, and PTB. We demonstrated that two AI models showed comparable performance in diagnosing three diseases. Both models effectively detected IPA and PTB but struggled to identify PM.

28 June 2025 in Mycoses
Verified
Journal Article
Closed access
YLYun Li
Yun Li
FHFeifei Huang
Feifei Huang
DCDeyan Chen
Deyan Chen
YZYouwen Zhang
Youwen Zhang
XZXia Zhang
Xia Zhang
JZJinping Zheng
Jinping Zheng

31 October 2023 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
YLY. Li
Y. Li
YSY. Shi
Y. Shi
XWXifeng Wu
Xifeng Wu
JPJ. Pang
J. Pang
JYJ. Yin
J. Yin
YSYang Shao
Yang Shao

29 September 2023 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Open access
JXJ. Xu
J. Xu
PWP. Wang
P. Wang
YLY. Li
Y. Li
XSXiaoshun Shi
Xiaoshun Shi
JYJ. Yu
J. Yu
FTFei Teng
Fei Teng